Medicine and Dentistry
Psoriasis
100%
Biological Marker
36%
Adalimumab
36%
Psoriasis Area and Severity Index
36%
Ustekinumab
32%
Treatment Response
29%
Inflammatory Disorder
27%
Allele
24%
Biological Product
22%
Meta-Analysis
21%
Acneiform Eruption
21%
Immunosuppressive Treatment
21%
Cohort Analysis
21%
Clinical Feature
21%
COVID-19 Vaccine
21%
Hair Follicle
21%
Mediator
21%
Ovary Follicle Development
21%
Cohort Study
21%
Morphogenesis
21%
Methotrexate
21%
Immunogenicity
21%
Diseases
15%
Odds Ratio
13%
Genome Wide Association Study
10%
T-Cell Response
10%
Acne Vulgaris
10%
Epidermolysis bullosa
10%
Dermatosis
10%
Health Care Cost
10%
Genetic Risk
10%
Transcription Factor
10%
Binding Site
10%
Genetic Predisposition
10%
Loss of Function Mutation
10%
Systemic Therapy
9%
Monotherapy
8%
Therapeutic Drug Monitoring
8%
Humoral Immunity
8%
Interleukin 23
8%
Neutralizing Antibody
8%
UK Biobank
7%
Psoriatic Arthritis
7%
Antibody Response
5%
TNF Inhibitor
5%
Immune Response
5%
Severe Acute Respiratory Syndrome Coronavirus 2
5%
Interleukin 17
5%
Steady State
5%
Immunology and Microbiology
Adalimumab
64%
Allele
48%
Genome-Wide Association Study
43%
Inflammatory Disorder
38%
Ustekinumab
37%
Biological Product
26%
Immunosuppression
21%
COVID-19
21%
Immunogenicity
21%
Genetic Risk
21%
Morphogenesis
21%
Mediator
21%
Genetic Predisposition
21%
Ovary Follicle Development
21%
Drug Concentration
21%
Hair Follicle
21%
Loss of Function Mutation
21%
Transcription Factor
21%
Sample Size
21%
Binding Site
21%
Peptides
21%
Drug Antibody
21%
Methotrexate
21%
HLA-DR
21%
Innate Immune System
10%
Xenobiotic
10%
Adaptive Immune System
10%
Scalp
10%
Gene Expression Assay
10%
Psoriatic Arthritis
10%
Spike
10%
Scar Formation
10%
T Cell
10%
Intravenous Immunoglobulin
10%
TNF Inhibitor
9%
ELISA
8%
Major Histocompatibility Complex
8%
Neutralizing Antibody
8%
Humoral Immunity
8%
Radioimmunoassay
6%
Genetic Susceptibility
5%
Gene Interaction
5%
Wild Type
5%
Interleukin 17
5%
Antibody Response
5%
Interleukin 23
5%
Immune Response
5%
Severe Acute Respiratory Syndrome Coronavirus 2
5%
Biochemistry, Genetics and Molecular Biology
Allele
69%
Genome-Wide Association Study
43%
Genetics
32%
Adalimumab
32%
Epidermolysis bullosa
21%
Genetic Predisposition
21%
Folliculogenesis
21%
Waist Circumference
21%
Genome Wide Association Study
21%
Genotyping
21%
Coding Region
21%
Binding Site
21%
Mediator
21%
Morphogenesis
21%
Genetic Risk
21%
Transcription Factor
21%
Drug Concentration
21%
Sample Size
21%
Loss of Function Mutation
21%
Cohort Study
21%
HLA-C
21%
HLA-B
21%
Epigenetics
10%
Transcriptome
10%
Gene Mapping
10%
Cell Maturation
10%
Hematopoietic Cell
10%
Biomarker Study
10%
Interferon
10%
Prevalence
10%
Comorbidity
10%
Ustekinumab
8%
Gene Expression Profiling
7%
Enzyme
7%
Missense
7%
Genomics
7%
Scar Formation
7%
Innate Immunity
7%
CYP1B1
7%
Adaptive Immunity
7%
Intravenous Immunoglobulin
7%